Molecular Target Therapy of AKT and NF-kB Signaling Pathways and Multidrug Resistance by Specific Cell Penetrating Inhibitor Peptides in HL-60 Cells
出版年份 2014 全文链接
标题
Molecular Target Therapy of AKT and NF-kB Signaling Pathways and Multidrug Resistance by Specific Cell Penetrating Inhibitor Peptides in HL-60 Cells
作者
关键词
-
出版物
Asian Pacific Journal of Cancer Prevention
Volume 15, Issue 10, Pages 4353-4358
出版商
Asian Pacific Organization for Cancer Prevention
发表日期
2014-09-17
DOI
10.7314/apjcp.2014.15.10.4353
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting mTOR for the treatment of AML. New agents and new directions.
- (2015) Jessica K. Altman et al. Oncotarget
- PAMAM Dendrimers Augment Inhibitory Effects of Curcumin on Cancer Cell Proliferation: Possible Inhibition of Telomerase
- (2014) Mahdie Mollazade et al. Asian Pacific Journal of Cancer Prevention
- Inhibitory Effects of β-Cyclodextrin-Helenalin Complexes on H-TERT Gene Expression in the T47D Breast Cancer Cell Line - Results of Real Time Quantitative PCR
- (2014) Samaneh Ghasemali et al. Asian Pacific Journal of Cancer Prevention
- Inhibition of Leptin and Leptin Receptor Gene Expression by Silibinin-Curcumin Combination
- (2014) Kazem Nejati-Koshki et al. Asian Pacific Journal of Cancer Prevention
- An electrochemical immunosensor for digoxin using core–shell gold coated magnetic nanoparticles as labels
- (2014) Anita Ahmadi et al. MOLECULAR BIOLOGY REPORTS
- Curcumin and Silibinin Inhibit Telomerase Expression in T47D Human Breast Cancer Cells
- (2013) Marzieh Nasiri et al. Asian Pacific Journal of Cancer Prevention
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Protein detection through different platforms of immuno-loop-mediated isothermal amplification
- (2013) Mohammad Pourhassan-Moghaddam et al. Nanoscale Research Letters
- Blastic Leukaemias (AML): A Biologist’s View
- (2012) Julio Roberto Cáceres-Cortés CELL BIOCHEMISTRY AND BIOPHYSICS
- Inhibition of leptin gene expression and secretion by silibinin: possible role of estrogen receptors
- (2012) Kazem Nejati-Koshki et al. CYTOTECHNOLOGY
- Docetaxel and 5-fluorouracil induce human p53 tumor suppressor gene transcription via a short sequence at core promoter element
- (2012) Jui-Chuan Chuang et al. TOXICOLOGY IN VITRO
- Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line
- (2012) Abolfazl Akbarzadeh et al. JOURNAL OF NANOBIOTECHNOLOGY
- Catalytic ozone oxidation of benzene at low temperature over MnOx/Al-SBA-16 catalyst
- (2012) Jong Hwa Park et al. Nanoscale Research Letters
- Backbone Cyclic Peptide Inhibitors of Protein Kinase B (PKB/Akt)
- (2011) Yftah Tal-Gan et al. JOURNAL OF MEDICINAL CHEMISTRY
- On the selectivity and efficacy of defense peptides with respect to cancer cells
- (2011) Frederick Harris et al. MEDICINAL RESEARCH REVIEWS
- Nanoimmunotherapy: application of nanotechnology for sustained and targeted delivery of antigens to dendritic cells
- (2011) Zhiping Zhang et al. Nanomedicine
- Nuclear initiated NF-κB signaling: NEMO and ATM take center stage
- (2010) Shigeki Miyamoto CELL RESEARCH
- Signal transduction therapy of cancer
- (2010) Alexander Levitzki et al. MOLECULAR ASPECTS OF MEDICINE
- Peptide Inhibitors Targeting Protein Kinases
- (2009) Hagit Eldar-Finkelman et al. CURRENT PHARMACEUTICAL DESIGN
- Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
- (2009) S. Park et al. HAEMATOLOGICA
- Cell penetrating peptide inhibitors of Nuclear Factor-kappa B
- (2008) J. S. Orange et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Multidrug Resistance in Acute Myeloid Leukemia: Potential New Therapeutics
- (2008) J. H. Weisburg JOURNAL OF NUCLEAR MEDICINE
- Deregulation of Signaling Pathways in Acute Myeloid Leukemia
- (2008) Claudia Scholl et al. SEMINARS IN ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More